Apneic Oxygenation Via Nasal Cannulae: 15 L/Min vs High-Flow

NCT02755389 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Apneic Oxygenation

Interventions

DRUG: 0 L/min oxygen via conventional nasal cannulae
DRUG: 15 L/min oxygen via conventional nasal cannulae
DRUG: 60 L/min oxygen via high-flow nasal cannulae

Sponsor

Nova Scotia Health Authority

Collaborators

[object Object]